In vivo organ specific drug delivery with implantable peristaltic pumps.

about

Ovariectomy uncovers purinergic receptor activation of endothelin-dependent natriuresis.

P2860

Q38806416-D2D180E4-0C03-4E25-AC1C-843BA99A3F6C

P2860

In vivo organ specific drug delivery with implantable peristaltic pumps.

Item

http://www.wikidata.org/entity/Q36906792

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

In vivo organ specific drug delivery with implantable peristaltic pumps.

@en

type

Item

label

In vivo organ specific drug delivery with implantable peristaltic pumps.

@en

prefLabel

In vivo organ specific drug delivery with implantable peristaltic pumps.

@en

P1476

In vivo organ specific drug delivery with implantable peristaltic pumps

@en

P2093

Joshua S Speed

http://www.w3.org/2001/XMLSchema#string

P2860

A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections

Dynamin activates NO production in rat renal inner medullary collecting ducts via protein-protein interaction with NOS1

Anticancer activities of histone deacetylase inhibitors

Quantitative analysis of aquaporin-2 phosphorylation.

Role of 20-hydroxyeicosatetraenoic acid in mediating hypertension in response to chronic renal medullary endothelin type B receptor blockade

Comparison of arterial pressure and plasma ANG II responses to three methods of subcutaneous ANG II administration.

Chronic central nervous system MC3/4R blockade attenuates hypertension induced by nitric oxide synthase inhibition but not by angiotensin II infusion

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.

Drug Delivery: Enabling Technology for Drug Discovery and Development. iPRECIO Micro Infusion Pump: Programmable, Refillable, and Implantable.

Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours.

P2888

srep26251

P304

26251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP26251

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kelly Hyndman

P577

2016-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

303317079

http://www.w3.org/2001/XMLSchema#string

P698

27185292

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

P932

4869096

http://www.w3.org/2001/XMLSchema#string

In vivo organ specific drug delivery with implantable peristaltic pumps.

about

P2860

P2860

In vivo organ specific drug delivery with implantable peristaltic pumps.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P921

P932